Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    NPJ precision oncology · 2025
    JTJones T. NauseefAAAlicia AlonsoBDBrian D. RobinsonASAndrea Sboner+5 more →JMJuan Miguel Mosquera
    PMID: 40155466PMCID: PMC11953479DOIFirst author2 citations

Publications

37 publications

Funding

3 grants

Active

1 grant
  • Co-I
    Novel Complex Structural Variants And Epigenetic Alterations Link The Genomes Of Prostate Cancer In African Americans With Outcome Disparity.
    U.S. Department of Defense · 2021–2026
    W81XWH-21-1-0762
Completed grants (2)
  • Co-I
    Unraveling the landscape of homologous recombination deficiency in patients with breast and prostate cancer across the African diaspora in NYC
    New York Genome Center Inc. · 2020–2024
    NYG 204878-01
  • PI
    A phase II trial using genomic preselection to identify castration-resistant prostate cancer patients who may benefit from cabozantinib
    The Asco Cancer Foundation · 2020–2022
    ASCO 201078-01

External relationships

Leadership Roles

Convergent Therapeutics, Inc.

Ownership

Convergent Therapeutics, Inc.

Speaker/Lecturer

AIQ Global, Inc.

Other Interest

MJH Life Sciences · UroToday